NCT06815172View on ClinicalTrials.gov

PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 28, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Pancreatic Adenocarcinoma
Trial Locations (1)

40138

Irccs Aoubo, Bologna

All Listed Sponsors
collaborator

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

OTHER

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER